CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.710
-0.110 (-2.88%)
At close: Apr 28, 2026, 4:00 PM EDT
3.780
+0.070 (1.89%)
After-hours: Apr 28, 2026, 5:25 PM EDT
CervoMed Stock Forecast
CRVO's stock price has decreased by -57.06% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CervoMed stock have an average target of 23, with a low estimate of 11 and a high estimate of 31. The average target predicts an increase of 519.95% from the current stock price of 3.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CervoMed stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +573.85% | Apr 23, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +735.58% | Apr 22, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +735.58% | Apr 8, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +735.58% | Mar 19, 2026 |
| Roth Capital | Roth Capital | Strong Buy Maintains $19 → $11 | Strong Buy | Maintains | $19 → $11 | +196.50% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
61.20K
from 4.01M
Decreased by -98.47%
Revenue Next Year
n/a
from 61.20K
EPS This Year
-2.48
from -2.98
EPS Next Year
-1.84
from -2.48
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 315,000 | n/a | ||||||
| Avg | 61,200 | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -92.1% | - | ||||||
| Avg | -98.5% | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.57 | -0.36 | ||||||
| Avg | -2.48 | -1.84 | ||||||
| Low | -4.25 | -2.39 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.